Gluten Reduction and Risk of Celiac Disease
Key facts
- Who runs it
- Lund University
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 1,141 people enrolled
- Started
- 5 May 2021
- Expected to end
- 31 Dec 2035
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Gluten reduced diet
- Record updated
- 13 April 2026
Who can take part
- Age
- 6 months to 6 months
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- children screened positive for HLA DQ2/X (X is neither DQ2 or DQ8)
- children who refused enrolment to the on-going study PreSiCe (ClinicalTrials.gov Identifier NCT03562221)
Who cannot take part
- congenital chronic disorder where intervention with diet may be affected
- written informed consent from both caregivers are missing
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Celiac disease shares many features of other autoimmune diseases such as type 1 diabetes. Recently, it was published that higher amounts of gluten intake increased the risk for celiac disease. Optimal amounts of gluten to be introduced during weaning have not yet been established. The aim is to investigate if a gluten-restricted diet (e.g. below 3 gram per day) during the first 3 years of life will reduce the risk of develop CDA and IA in genetically predisposed children by the age of 7 years. Children who screened positive for HLA DQ2/X (X is neither DQ2 nor DQ8) in the GPPAD-02 (ASTR1D [ClinicalTrials.gov Identifier NCT03316261]) screening will be contacted by a study nurse.
The 2 groups in the trial
- No interventionNo study treatment, for comparison
The group will be followed without any intervention, with regular visits at the research clinic.
- Gluten reduced dietTreatment being tested
Subjects will follow a diet that does not exceed a daily intake of 3 gram gluten. The group will be followed with regular visits at the research clinic.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Gluten Reduction After Infancy and Risk of Celiac Disease
- Record updated
- 13 April 2026